Citadel Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $480M | Sell |
|
|||||
|
2023
Q2 | $459M | Buy |
|
|||||
|
2023
Q1 | $434M | Buy |
|
|||||
|
2022
Q4 | $144M | Sell |
|
|||||
|
2022
Q3 | $169M | Buy |
|
|||||
|
2022
Q2 | $36.2M | Buy |
|
|||||
|
2022
Q1 | $18.4M | Sell |
|
|||||
|
2021
Q4 | $131M | Sell |
|
|||||
|
2021
Q3 | $198M | Buy |
|
|||||
|
2021
Q2 | $162M | Buy |
|
|||||
|
2021
Q1 | $88.2M | Buy |
|
|||||
|
2020
Q4 | $46.7M | Sell |
|
|||||
|
2020
Q3 | $99.8M | Sell |
|
|||||
|
2020
Q2 | $205M | Buy |
|
|||||
|
2020
Q1 | $107M | Buy |
|
|||||
|
2019
Q4 | $49.5M | Buy |
|
|||||
|
2019
Q3 | $13.6M | Sell |
|
|||||
|
2019
Q2 | $28.4M | Buy |
|
|||||
|
2019
Q1 | $9.93M | Buy |
|
|||||
|
2018
Q4 | $2.13M | Sell |
|
|||||
|
2018
Q3 | $4.07M | Buy |
|
|||||
|
2018
Q2 | $245K | Sell |
|
|||||
|
2018
Q1 | $2.69M | Sell |
|
|||||
|
2017
Q4 | $9.55M | Sell |
|
|||||
|
2017
Q3 | $20.9M | Sell |
|
|||||
|
2017
Q2 | $47.2M | Buy |
|
|||||
|
2017
Q1 | $4.15M | Sell |
|
|||||
|
2016
Q4 | $6.39M | Buy |
|
|||||
|
2016
Q3 | $5.66M | Buy |
|
|||||
|
2016
Q2 | $1.45M | Sell |
|
|||||
|
2016
Q1 | $36M | Buy |
|
|||||
|
2015
Q4 | $11.1M | Buy |
|
|||||
|
2015
Q3 | $5.15M | Sell |
|
|||||
|
2015
Q2 | $62.2M | Buy |
|
|||||
|
2015
Q1 | $17.2M | Buy |
|
|||||
|
2014
Q4 | $846K | Sell |
|
|||||
|
2014
Q3 | $2.2M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.13M | Sell |
|
|||||
|
2013
Q4 | $718K | Buy |
|
|||||
|
2013
Q3 | $236K | Buy |
|
|||||
|
2013
Q2 | $145K | Buy |
|